Carbidopa
Carbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
United States
$56
per month
India
$1
per month
You save
−97%save $54/mo · 97% cheaper
22K US scripts/yr$1.2M potential annual savings$1.2M US spend/yr
Drag to rotate · 3D structureC10H14N2O4
SMILES: C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN
Compare the price
US price$56per month
India price$1per month
You save$5497% less
Based on 30 units per month. US $1.86 vs India $0.05 per unit.
Total over 1 periodSave $54$56 → $1
The bigger picture
Carbidopa is filled about 22K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$1.2M
If sourced from India
$32.4K
Potential annual savings
$1.2M
−97%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.